10.03
+0.02
+(0.25%)
At close: April 17 at 4:00:00 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
119,168
136,823
101,794
191,060
Total Liabilities Net Minority Interest
85,809
95,726
19,130
22,131
Total Equity Gross Minority Interest
33,359
41,097
82,664
168,929
Total Capitalization
33,359
41,097
82,664
168,929
Common Stock Equity
33,359
41,097
82,664
168,929
Capital Lease Obligations
3,089
2,342
3,465
6,476
Net Tangible Assets
33,359
41,097
82,664
168,929
Working Capital
67,700
94,562
80,671
138,131
Invested Capital
33,359
41,097
82,664
168,929
Tangible Book Value
33,359
41,097
82,664
168,929
Total Debt
3,089
2,342
3,465
6,476
Share Issued
6,356.29
5,482.75
4,074.58
4,010.04
Ordinary Shares Number
6,356.29
5,482.75
4,074.58
4,010.04
12/31/2021 - 12/17/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SPRO Spero Therapeutics, Inc.
0.7542
+1.92%
CLRB Cellectar Biosciences, Inc.
0.2990
+5.58%
TBPH Theravance Biopharma, Inc.
8.62
+0.29%
IPSC Century Therapeutics, Inc.
0.5437
+8.74%
EPIX ESSA Pharma Inc.
1.7900
+1.13%
RPTX Repare Therapeutics Inc.
1.2000
+4.35%
KZR Kezar Life Sciences, Inc.
4.1600
+2.46%
HLVX HilleVax, Inc.
1.6900
+2.42%
LVTX LAVA Therapeutics N.V.
1.3100
+6.50%
GLTO Galecto, Inc.
2.4300
+2.10%